For research use only. Not for therapeutic Use.
CP55,667 is a CB2-selective antagonist.
| Catalog Number | I006233 |
| CAS Number | 83002-04-4 |
| Synonyms | CP55,667; CP-55,667; CP 55667; CP-55667.;2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol |
| Molecular Formula | C24H40O3 |
| Purity | ≥95% |
| Target | CB2 Antagonist |
| Solubility | Soluble in DMSO |
| Storage | -20°C |
| InChIKey | YNZFFALZMRAPHQ-SYYKKAFVSA-N |
| Reference | </br>1: Chuchawankul S, Shima M, Buckley NE, Hartmann CB, McCoy KL. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int Immunopharmacol. 2004 Feb;4(2):265-78. PubMed PMID: 14996418.</br>2: Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 2000 Jan 1;29(1):58-69. PubMed PMID: 10594923.</br>3: Burnette-Curley D, Cabral GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Proc Soc Exp Biol Med. 1995 Oct;210(1):64-76. PubMed PMID: 7675800.</br>4: Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther. 1988 Dec;247(3):1046-51. PubMed PMID: 2849657.</br></br> |
